What is CLS Holdings USA Earnings Yield (Joel Greenblatt) %?
CLS Holdings USA's Enterprise Value for the quarter that ended in Feb. 2024 was $14.11 Mil.
CLS Holdings USA's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-6.60 Mil. CLS Holdings USA's Earnings Yield (Joel Greenblatt) for the quarter that ended in Feb. 2024 was -46.73%.
The historical rank and industry rank for CLS Holdings USA's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
CLSH'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -120.12 Med: -35.48 Max: 5.67
Current: -41.32
During the past 11 years, the highest Earnings Yield (Joel Greenblatt) of CLS Holdings USA was 5.67%. The lowest was -120.12%. And the median was -35.48%.
CLSH's Earnings Yield (Joel Greenblatt) % is ranked worse than 87.92% of 1093
companies
in the Drug Manufacturers industry
Industry Median: 2.49
vs CLSH: -41.32
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. CLS Holdings USA's Forward Rate of Return (Yacktman) % for the quarter that ended in Feb. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
CLS Holdings USA Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for CLS Holdings USA's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
CLS Holdings USA Earnings Yield (Joel Greenblatt) % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CLS Holdings USA's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where CLS Holdings USA's Earnings Yield (Joel Greenblatt) % falls into.
CLS Holdings USA Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
CLS Holdings USAs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in May. 2023 is calculated as
CLS Holdings USA's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.60 Mil.
CLS Holdings USA (OTCPK:CLSH) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
CLS Holdings USA Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of CLS Holdings USA's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
CLS Holdings USA (CLS Holdings USA) Business Description
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLSH has been successfully added to your 